2022
The role of lung cancer risk and comorbidity in lung cancer screening use
Richman IB, Long JB, Poghosyan H, Sather P, Gross CP. The role of lung cancer risk and comorbidity in lung cancer screening use. Preventive Medicine Reports 2022, 30: 102006. PMID: 36203942, PMCID: PMC9530957, DOI: 10.1016/j.pmedr.2022.102006.Peer-Reviewed Original ResearchLung cancer screeningLung cancer riskDiagnostic chest CTCancer riskLow comorbidityCancer screeningChest CTGreater lung cancer riskHigher lung cancer riskLow-dose computed tomographyCancer screening useLung cancer mortalityDose computed tomographyElectronic health recordsLCS useCohort studyPatient characteristicsEligible adultsCancer mortalityScreening useComorbiditiesComputed tomographyDiagnostic CTDiagnostic imagingPatients
2018
Tobacco treatment implementation within 28 commission on cancer accredited programs in the Northeast region of the USA: A pilot study
Cooley M, Poghosyan H, Sprunck-Harrild K, Winickoff J, Edge S, Emmons K. Tobacco treatment implementation within 28 commission on cancer accredited programs in the Northeast region of the USA: A pilot study. Translational Behavioral Medicine 2018, 8: 706-713. PMID: 29528457, PMCID: PMC6454513, DOI: 10.1093/tbm/ibx024.Peer-Reviewed Original ResearchConceptsTobacco treatmentCancer survivorsCancer programsAmerican College of Surgeons Commission on CancerSmoking statusImplementation of decision aidsDeliver tobacco treatmentTobacco treatment guidelinesTobacco treatment interventionsTobacco treatment servicesTobacco control programsSystem-wide programTobacco cessation programsElectronic health recordsCommission on CancerRisk of cancer recurrenceDiagnosis of cancerCare QuestionnaireCessation supportCare deliveryIdentified smokersHealth recordsCessation programsCommunity linkagesContinued smoking